1. |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin, 2017, 67(1): 7-30.
|
2. |
Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin, 2017, 67(2): 100-121.
|
3. |
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin, 2016, 66(4): 271-289.
|
4. |
Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2018, 29(Suppl 4): iv192-iv237.
|
5. |
Wang Y, Li Y, Chen P, et al. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis. Ann Transl Med, 2019, 7(18): 433.
|
6. |
Wang Y, Huang D, Xu WY, et al. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in non-small cell lung cancer: a meta-analysis. Oncol Res Treat, 2019, 42(10): 523-531.
|
7. |
Wang Y, Li S, Hu X, et al. The prognostic value of serum albumin-globulin ratio in early-stage non-small cell lung cancer: a retrospective study. Cancer Manag Res, 2019, 11: 3545-3554.
|
8. |
王彦, 吴砚铭, 王彦文, 等. C 反应蛋白/白蛋白比值与肺癌患者预后关系的meta分析. 华西医学, 2019, 34(1): 50-57.
|
9. |
Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta, 2010, 1800(8): 760-769.
|
10. |
Alkhateeb AA, Connor JR. The significance of ferritin in cancer: anti-oxidation, inflammation and tumorigenesis. Biochim Biophys Acta, 2013, 1836(2): 245-254.
|
11. |
Milman N, Sengeløv H, Dombernowsky P. Iron status markers in patients with small cell carcinoma of the lung. Relation to survival. Br J Cancer, 1991, 64(5): 895-898.
|
12. |
Ferrigno D, Buccheri G. A comprehensive evaluation of serum ferritin levels in lung cancer patients. Lung Cancer, 1992, 8(2): 85-94.
|
13. |
Milman N, Pedersen LM. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol Rep, 2002, 9(1): 193-198.
|
14. |
Erbaycu AE, Uçar H, Uslu O, et al. Prognostic significance of serum iron, iron-binding capacity, ferritin and bronchoalveolar lavage ferritin levels in primary lung cancer. UHOD-Uluslar Hematol, 2008, 18(4): 217-225.
|
15. |
赵伟庆, 石红兵, 吴昌平, 等. 血清铁蛋白的表达与晚期肺癌患者预后的关系. 江苏医药, 2014, 40(24): 2978-2980.
|
16. |
谢锦华, 吉浩明, 陈国栋, 等. 小细胞肺癌患者血清铁蛋白, 红细胞沉降率和红细胞平均指数水平与预后的关系. 国际肿瘤学杂志, 2018, 45(8): 465-469.
|
17. |
Ma C, Zuo W. Preoperative serum bilirubin levels associated with stage and prognosis in patients with stages I-III of non-small cell lung cancer in Jiangxi province, China. Int J Clin Exp Med, 2019, 12(8): 10433-10442.
|
18. |
Lee S, Jeon H, Shim B. Prognostic value of ferritin-to-hemoglobin ratio in patients with advanced non-small-cell lung cancer. J Cancer, 2019, 10(7): 1717-1725.
|
19. |
Wells G, Shea BJ, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric, 2014, 18(6): 727-734.
|
20. |
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560.
|
21. |
Kuvibidila SR, Gauthier T, Rayford W. Serum ferritin levels and transferrin saturation in men with prostate cancer. J Natl Med Assoc, 2004, 96(5): 641-649.
|
22. |
Lorenzi M, Lorenzi B, Vernillo R. Serum ferritin in colorectal cancer patients and its prognostic evaluation. Int J Biol Markers, 2006, 21(4): 235-241.
|
23. |
Singh KJ, Singh SK, Suri A, et al. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage. Indian J Cancer, 2005, 42(4): 197-200.
|
24. |
Ashourpour M, Djalali M, Djazayery A, et al. Relationship between serum ferritin and inflammatory biomarkers with insulin resistance in a Persian population with type 2 diabetes and healthy people. Int J Food Sci Nutr, 2010, 61(3): 316-323.
|
25. |
王彦, 林琳, 戢艳丽, 等. 术前红细胞分布宽度与食管癌患者预后关系的系统评价与 Meta 分析. 中国胸心血管外科临床杂志, 2019, 26(12): 1247-1251.
|